AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$20.87
−$0.74 (−3.40%) 4:00 PM ET
After hours$20.80
−$0.06 (−0.31%) 5:45 PM ET
Prev closePrevC$21.60
OpenOpen$21.09
Day highHigh$21.16
Day lowLow$20.42
VolumeVol462,109
Avg volAvgVol413,219
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$563.59M
P/E ratio
-45.36
FY Revenue
$107.53M
EPS
-0.46
Gross Margin
87.17%
Sector
Technology
AI report sections
MIXED
CEVA
CEVA, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+6% (Above avg)
Vol/Avg: 1.06×
RSI
51.19(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.01 (Strong)
MACD: 0.02 Signal: 0.01
Short-Term
-0.04 (Weak)
MACD: -0.46 Signal: -0.42
Long-Term
-0.15 (Weak)
MACD: -0.42 Signal: -0.27
Intraday trend score
58.00
LOW30.00HIGH58.00
Latest news
CEVA•12 articles•Positive: 0Neutral: 3Negative: 2
NegativeThe Motley Fool• Eric Volkman
Why AI Stock Ceva Was Sliding Hard This Week
Ceva announced a secondary stock offering of 3 million shares at $19.50 per share, causing its stock price to drop over 22% for the week due to potential shareholder dilution.
Stock price dropped significantly after announcing a new share issuance that could dilute existing shareholders' value, with potential concerns about the company's financial strategy
NeutralBenzinga• Prnewswire
CEVA ANNOUNCES THE PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK
Ceva, Inc. announced a public offering of 3,000,000 shares at $19.50 per share, expecting to raise approximately $58.5 million to fund potential acquisitions, investments, and general corporate purposes.
The company is raising capital through a standard public stock offering to increase financial flexibility and fund potential strategic investments, which suggests a proactive but not overtly positive or negative business strategy
NegativeThe Motley Fool• Eric Volkman
Why AI Stock Ceva Was Tumbling Hard This Week
Ceva, a financial services company, reported a 10% year-over-year increase in revenue for the first quarter, but missed analyst expectations on both revenue and profitability. The company also lowered its revenue and profitability guidance for 2025, leading to a stock price decline of over 25% week-to-date.
CEVACevafinancial servicesearnings reportguidance
Sentiment note
Ceva's Q1 earnings report missed analyst expectations on both revenue and profitability, and the company lowered its guidance for 2025, leading to a significant decline in its stock price.
Jim Cramer Keeps Recommending Tesla Because He Loves 'Space Stuff,' But He's Not Keen On Ford: 'I Can't Recommend The Stock'
Jim Cramer expressed his enthusiasm for space exploration and Tesla, but was not keen on recommending Ford's stock. He also shared his thoughts on CEVA, Schlumberger, and Vistra.
TSLAFFPBFPCJim CramerTeslaFordCEVA
Sentiment note
The article mentions CEVA as one of the companies Cramer discussed, but does not provide any specific sentiment or reasoning.
NeutralGlobeNewswire Inc.• Researchandmarkets.Com
Poultry Vaccines Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report 2024
The poultry vaccines market is projected to grow from $2.1 billion in 2023 to $4.1 billion by 2031, driven by the rising prevalence of poultry diseases. Advancements in vectored and combination vaccines are expected to be key market trends.
The article lists Ceva as one of the key players in the poultry vaccines market, but does not offer any insights into the company's performance or outlook.
UnknownZacks Investment Research• Zacks Equity Research
Ceva (CEVA) delivered earnings and revenue surprises of -266.67% and 4.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CEVAPXLW
UnknownZacks Investment Research• Zacks Equity Research
CEVA Unveils Multi-Protocol Wireless Platform IP for IoT
CEVA introduces a portfolio of multi-protocol wireless platform intellectual property called Ceva-Waves Links.
NVDACEVABILLBSY
UnknownMarketWatch• MarketWatch
Nvidia’s stock sees one advantage that only two other chip makers share
Nvidia provides an example of how growth investors can miss out if they are fixated on price ratios.
NVDASOXXMIDONTO
UnknownBenzinga• Avi Kapoor
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.
Sony Group reported third-quarter FY23 sales growth of 22% year-on-year to $25.34 billion (¥3.75 trillion), beating the consensus of $24.62 billion. Adjusted EPS of $1.99 beat the consensus of $1.65.
Sony revised its FY23 sales outlook to $86.62 billion (¥12.4 trillion), down from a prior forecast of ¥12.3 trillion versus the consensus of $87.32 billion.
Sony Group shares fell 6.3% to $89.86 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Datasea Inc. (NASDAQ: DTSS) shares jumped 1,173% to $18.59. On Tuesday, Datasea posted a narrower second-quarter loss.
Earlyworks Co., Ltd. (NASDAQ: ELWS) surged 416% to $2.35 on two passive stakes.
enGene Holdings Inc. (NASDAQ: ENGN) jumped 95.5% to $14.90. The company’s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day’s closing price.
Cineverse Corp. (NASDAQ: CNVS) surged 92.9% to $2.9899. Cineverse announced forthcoming launch of AI-powered movie search platform cineSearch.
Cheche Group Inc. (NASDAQ: CCG) gained 74.3% to $5.49.
MGO Global, Inc. (NASDAQ: MGOL) rose 66% to $0.6647.
Cogent Biosciences, Inc. (NASDAQ: COGT) surged 62.7% to $8.89.
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) gained 35% to $1.29 after the company announced it received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART500 device.
Lyft, Inc. (NASDAQ: LYFT) shares gained 34.3% to $16.29 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 ...
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.
Shares of Charles River Laboratories International, Inc. (NYSE: CRL) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter results and issued guidance above estimates.
Charles River posted adjusted earnings of $2.46 per share, beating market estimates of $2.40 per share. The company’s quarterly sales came in at $1.01 billion versus expectations of $991.25 million.
Charles River Laboratories International, Inc. (NYSE: CRL) rose 7.2% to $236.00 on Wednesday.
Here are some other big stocks recording gains in today’s session.
Lyft, Inc. (NASDAQ: LYFT) shares rose 34.3% to $16.29 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company’s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.
Healthcare Services Group, Inc. (NASDAQ: HCSG) rose 25.7% to $11.90 following upbeat earnings.
Larimar Therapeutics, ...
UnknownZacks Investment Research• Zacks Equity Research
Ceva (CEVA) Q4 Earnings Top Estimates
Ceva (CEVA) delivered earnings and revenue surprises of 66.67% and 0.67%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CEVANVMI
UnknownMarketWatch• MarketWatch
Nvidia pulls further away from other chip makers by this one measure
In a dynamic industry such as semiconductors, consensus estimates that support stock prices can change quickly.
NVDASOXXMIDMU
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal